Clinical Trials Browser

Phase 2 × UNKNOWN × HMPL-013 × Clear all

NCT05279677 2022-08-23

FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms

NCT04695470 2021-01-07

Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer Patients

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms